MERS-CoVは,ウイルスの複製複合体での凝縮を阻害することによって,PKRの活性化を阻害する
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
中東呼吸器症候群コロナウイルス (MERS-CoV) は,タンパク質キナーゼR (PKR) 経路に逆らいます. MERS-CoVのNS4aタンパク質は,先天的な免疫の重要なステップであるウイルス dsRNAのPKR凝縮を阻害することによって,PKR活性化を防ぐ.
科学分野:
- ウイルス学
- 免疫学
- 分子生物学
背景:
- 中東呼吸器症候群コロナウイルス (MERS-CoV) は,先天的な免疫反応を抑制する病原性ウイルスです.
- タンパク質キナーゼR (PKR) 経路は,MERS-CoVが標的とする先天的な免疫システムの重要な構成要素です.
研究 の 目的:
- MERS-CoVに対するPKR活性化のメカニズムを調査する.
- MERS-CoVがPKR経路を逆転させる方法を解明する.
主な方法:
- 免疫刺激性MERS-CoV変異体を使用し,不活性なエンドロビヌクレアースUと付属タンパク質NS4aを削除しました.
- 双膜膀 (DMV) と関連したウイルスのdsRNAのPKR凝縮と活性化が観察されました.
- PKR阻害におけるMERS-CoV NS4aタンパク質の役割を調べました.
主要な成果:
- PKRは,DMVの近くのウイルス dsRNAに凝縮され,eIF2αをリン酸化して解離する.
- MERS-CoVのNS4aタンパク質は,dsRNAと結合し,PKR凝縮を防ぐことでPKR活性化を阻害する.
- ジカウイルスに対する反応としてPKRの凝縮と活性化も観察された.
結論:
- PKRの活性化には,複製複合体におけるウイルスのdsRNAの凝縮が含まれており,その後にオートフォスフォリレーションと細胞転移が続きます.
- MERS-CoV NS4aは,PKR凝縮を阻害することで,この抗ウイルス経路に敵対する.
- この研究は,陽性鎖RNAウイルスによるPKR活性化とMERS-CoVの免疫回避戦略のモデルを提供します.
関連する概念動画
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
GPCR Desensitization
6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K


